Shoeshine: Will F&P Healthcare hit Trump's wall?
NZ-listed company faces a Tijuana challenge — but one analyst says it's underpriced regardless.
Fisher & Paykel Healthcare is not a glamorous company. It is never going to impress people with its beautiful products, slick marketing campaigns or its quick flight to success.
It makes useful things, lifesaving things; masks to help people breathe more easily, either in hospital through its
Want to read more? It's easy.
Choose your best value subscription option
Individual
Group membership
NBR Marketplace
Yearly Premium Online Subscription
NZ$499.00 / yearly
Monthly Premium Online Subscription
NZ$44.95 / monthly
Smartphone Only Subscription
NZ$24.95 / monthly
Premium Group Membership 10 Users
NZ$350+GST / monthly
$35 per user - Pay by monthly credit card debitPremium Group Membership 20 Users
NZ$600+GST / monthly
$30 per user - Pay by monthly credit card debitPremium Group Membership 50 Users
NZ$1250+GST / monthly
$25 per user - Pay by monthly credit card debitPremium Group Membership 100 Users
NZ$1875+GST / monthly
$18.75 per user - Pay by monthly credit card debitYearly Premium Online Subscription + NBR Marketplace
NZ$499.00 / yearly
Already have an account? Login
Shoeshine
Sat, 19 Nov 2016
Sat, 19 Nov 2016
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Shoeshine: Will F&P Healthcare hit Trump's wall?
Shoeshine,
63205